Frontal Lobe Epilepsy 

  • Author: Sheryl Haut, MD; Chief Editor: Selim R Benbadis, MD   more...
 
Updated: May 24, 2011
 

Background

Frontal lobe epilepsy is characterized by recurrent seizures arising from the frontal lobes. Frequently, seizure types are simple partial or complex partial, often with secondary generalization. Clinical manifestations tend to reflect the specific area of seizure onset and range from behavioral to motor or tonic/postural changes. Status epilepticus may be associated more commonly with frontal lobe seizures than with seizures arising from other areas.

Seizures may arise from any of the frontal lobe areas, including orbitofrontal, frontopolar, dorsolateral, opercular, supplementary motor area, motor cortex, or cingulate gyrus.

Disease conditions commonly associated with frontal lobe epilepsy are frequently symptomatic, including congenital causes (such as cortical dysgenesis, gliosis, vascular malformations), neoplasms, head trauma, infections, and anoxia.

Owing to advances in genetic analysis, an expanded number of genetically inherited frontal lobe epilepsy syndromes have been described. Many of these syndromes are characterized by autosomal dominant inheritance, belonging to a group known as the autosomal dominant nocturnal frontal lobe epilepsies (ADNFLE).

Quality-of-life issues for patients with epilepsy can include the following:

  • Coping with the social stigma of epilepsy
  • Living with restrictions
  • Living with long-term medical therapy

For more information, see Simple Partial Seizures, Complex Partial Seizures, and Status Epilepticus.

Go to Epilepsy and Seizures for an overview of this topic.

Next

Etiology

Tumors

Reviews indicate that the epileptogenic lesion in approximately one third of patients with refractory frontal lobe seizures is a tumor.

Common tumors causing frontal lobe epilepsy include gangliogliomas, low-grade gliomas, and epidermoid tumors. High-grade tumors more often present with headache or focal deficits, but many are associated with seizures at some time in their course.

Head trauma

Head trauma is a very frequent cause of damage to the frontal lobes. Risk of later epilepsy depends largely on the severity of trauma. The first seizure usually occurs within months, but may not occur for many years.

Pathologic examination of the frontal lobe frequently reveals meningocerebral cicatrix.

Vascular malformations

Three main types are recognized: arteriovenous malformations, cavernous angiomas, and venous angiomas. Arteriovenous malformations and cavernous angiomas are more likely to cause seizures than are venous angiomas.

Developmental lesions

With improvements in neuroimaging, cortical dysplasias increasingly are being recognized as epileptogenic lesions. Other common developmental causes of frontal lobe seizures include hamartomas and nodular heterotopias.

Gliosis

Gliosis is identified in many pathologic specimens following surgical resection for frontal lobe epilepsy. It may follow head trauma, neonatal anoxia, or previous resection; often, no cause is identified.

Encephalitis

Although encephalitis commonly produces temporal lobe epilepsy, frontal lobe seizures may occur.

Inherited frontal lobe epilepsy

Three types of ADNFLE have been described. They are clinically characterized by brief, nocturnal motor seizures that often occur in clusters, mainly during non-REM sleep. Seizures may also occur during daytime naps. A brief aura is typically followed by hyperkinetic or tonic activity and typically shows a good response to carbamazepine. Differentiation from parasomnias remains a challenge.

ADNFLE was the first partial epilepsy identified as a single gene disorder. Mutations in 2 nicotinic acetylcholine receptor genes (nAChR alpha4 and beta2 subunits) have been associated with ADNFLE, with a third potential locus identified.[1] Nicotine use is reported to be associated with decreased seizure frequency in patients with these mutations.[2]

Positron emission tomography (PET) scan studies in ADNFLE demonstrate decreased nAChR density in the right dorsolateral prefrontal region, but increased density in mesencephalon. Dopaminergic pathways in the striatum have been shown to be altered in ADNFLE.[3]

Other familial frontal lobe epilepsies have been identified, including a familial partial epilepsy with variable foci linked to chromosome 22.

Previous
Next

Epidemiology

The exact incidence of frontal lobe epilepsy is not known. In most centers, however, frontal lobe epilepsy accounts for 20-30% of operative procedures involving intractable epilepsy.

Sex predilection

No significant sex-based frequency difference has been reported for frontal lobe epilepsy in epidemiologic studies. However, a comparison of frontal lobe versus temporal lobe seizures captured during epilepsy monitoring has suggested a male predominance in frontal lobe seizures.[4]

Age predilection

Symptomatic frontal lobe epilepsy may affect patients of all ages.

In a large series of cases, the mean subject age was 28.5 years, with age of epilepsy onset 9.3 years for left frontal epilepsy and 11.1 years for right frontal epilepsy.

Morbidity

Complications of frontal lobe epilepsy may include status epilepticus or a comorbid psychiatric or behavioral disturbance.

Status epilepticus is reported in up to 25% of patients with frontal lobe epilepsy. The episodes may be convulsive, nonconvulsive, or simple partial.

Previous
Next

Prognosis

Approximately 65-75% of patients with frontal lobe seizures respond to appropriate anticonvulsants and become seizure free.

The proportion of patients with medically refractory frontal lobe epilepsy who become seizure free from additional medications or surgical options is lower than in patients with temporal lobe epilepsy.

An important feature in prognosis is the early recognition of frontal lobe seizures as an epileptic syndrome rather than as a parasomnia or a psychiatric condition.

Previous
Next

Patient Education

Patient education is important for all patients with epilepsy. Many patients benefit from joining one of the national or regional epilepsy support groups.

Activity restrictions

Patients with epilepsy who are not seizure free have the following restrictions:

  • Driving - Duration of restriction varies by state
  • Operating heavy machinery
  • Activities that involve unprotected heights
  • Swimming alone
Previous
 
 
Contributor Information and Disclosures
Author

Sheryl Haut, MD  Associate Professor of Clinical Neurology, Program Director, Neurology Residency Training Program, Albert Einstein College of Medicine; Director, Adult Epilepsy, Montefiore Medical Center

Sheryl Haut, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and American Neurological Association

Disclosure: Jazz Consulting fee Consulting; Endo Grant/research funds Research; Acorda Consulting fee Consulting; Vivus Consulting fee Consulting

Specialty Editor Board

Edward B Bromfield, MD  Associate Professor of Neurology, Faculty Member, Division of Sleep Medicine, Harvard Medical School; Chief, Division of EEG, Epilepsy and Sleep Neurology, Consulting Neurologist, Brigham and Women's Hospital

Edward B Bromfield, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, American Neurological Association, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: eMedicine Salary Employment

Jose E Cavazos, MD, PhD, FAAN  Associate Professor with Tenure, Departments of Neurology, Pharmacology, and Physiology, Program Director of the Clinical Neurophysiology Fellowship, University of Texas School of Medicine at San Antonio; Co-Director, South Texas Comprehensive Epilepsy Center, University Hospital System; Director of the San Antonio Veterans Affairs Epilepsy Center of Excellence and Neurodiagnostic Centers, Audie L Murphy Veterans Affairs Medical Center

Jose E Cavazos, MD, PhD, FAAN is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and American Neurological Association

Disclosure: GXC Global, Inc. Intellectual property rights Medical Director - company is to develop a seizure detecting device. No conflict with any of the eMedicine articles that I wrote or edited.

Chief Editor

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

References
  1. Picard F, Bruel D, Servent D, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. Aug 2006;129(Pt 8):2047-60. [Medline].

  2. Brodtkorb E, Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav. Nov 2006;9(3):515-520. [Medline].

  3. Fedi M, Berkovic SF, Scheffer IE, O'Keefe G, Marini C, Mulligan R, et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology. Sep 9 2008;71(11):795-8. [Medline].

  4. O'Brien TJ, Mosewich RK, Britton JW, Cascino GD, So EL. History and seizure semiology in distinguishing frontal lobe seizures and temporal lobe seizures. Epilepsy Res. Dec 2008;82(2-3):177-82. [Medline].

  5. So NK. Mesial frontal epilepsy. Epilepsia. 1998;39 Suppl 4:S49-61. [Medline].

  6. Kotagal P, Arunkumar GS. Lateral frontal lobe seizures. Epilepsia. 1998;39 Suppl 4:S62-8. [Medline].

  7. Williamson PD, Spencer DD, Spencer SS, Novelly RA, Mattson RH. Complex partial seizures of frontal lobe origin. Ann Neurol. Oct 1985;18(4):497-504. [Medline].

  8. Laskowitz DT, Sperling MR, French JA, O'Connor MJ. The syndrome of frontal lobe epilepsy: characteristics and surgical management. Neurology. Apr 1995;45(4):780-7. [Medline].

  9. Knake S, Triantafyllou C, Wald LL, Wiggins G, Kirk GP, Larsson PG, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. Oct 11 2005;65(7):1026-31. [Medline].

  10. Bonelli SB, Lurger S, Zimprich F, Stogmann E, Assem-Hilger E, Baumgartner C. Clinical seizure lateralization in frontal lobe epilepsy. Epilepsia. Mar 2007;48(3):517-23. [Medline].

  11. Mosewich RK, So EL, O'Brien TJ, Cascino GD, Sharbrough FW, Marsh WR, et al. Factors predictive of the outcome of frontal lobe epilepsy surgery. Epilepsia. Jul 2000;41(7):843-9. [Medline].

  12. Elsharkawy AE, Alabbasi AH, Pannek H, Schulz R, Hoppe M, Pahs G, et al. Outcome of frontal lobe epilepsy surgery in adults. Epilepsy Res. Oct 2008;81(2-3):97-106. [Medline].

  13. Jeha LE, Najm I, Bingaman W, Dinner D, Widdess-Walsh P, Lüders H. Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain. Feb 2007;130:574-84. [Medline].

  14. Kossoff EH, Rowley H, Sinha SR, Vining EP. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. Feb 2008;49(2):316-9. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.